All 'Bye' Itself: Alcon Spins Out From Novartis In $25Bn Stock Listing

 
• By Catherine Longworth
  
Close-up of blue eye. High Technologies in the futuristic. : cataract
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Ophthalmology

More from Device Area